227 related articles for article (PubMed ID: 35196008)
21.
Zhai J; Tan FH; Luwor RB; Srinivasa Reddy T; Ahmed N; Drummond CJ; Tran N
ACS Appl Bio Mater; 2020 Jul; 3(7):4198-4207. PubMed ID: 35025421
[TBL] [Abstract][Full Text] [Related]
22. Lyotropic liquid crystalline 2D and 3D mesophases: Advanced materials for multifunctional anticancer nanosystems.
Araújo-Silva H; Teixeira PV; Gomes AC; Lúcio M; Lopes CM
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189011. PubMed ID: 37923232
[TBL] [Abstract][Full Text] [Related]
23. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
24. Metallo-Cubosomes: Zinc-Functionalized Cubic Nanoparticles for Therapeutic Nucleotide Delivery.
Tajik-Ahmadabad B; Chollet L; White J; Separovic F; Polyzos A
Mol Pharm; 2019 Mar; 16(3):978-986. PubMed ID: 30648870
[TBL] [Abstract][Full Text] [Related]
25. Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.
Hu CM; Kaushal S; Tran Cao HS; Aryal S; Sartor M; Esener S; Bouvet M; Zhang L
Mol Pharm; 2010 Jun; 7(3):914-20. PubMed ID: 20394436
[TBL] [Abstract][Full Text] [Related]
26. A Synoptic Update on Smart Lipid Nanocarrier: Cubosomes, and their Design Development, and Recent Challenges.
Sreelaya P; Bhattacharya S
Curr Pharm Biotechnol; 2024; 25(4):434-447. PubMed ID: 37211845
[TBL] [Abstract][Full Text] [Related]
27. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model.
Ding Y; Chow SH; Chen J; Brun APL; Wu CM; Duff AP; Wang Y; Song J; Wang JH; Wong VHY; Zhao D; Nishimura T; Lee TH; Conn CE; Hsu HY; Bui BV; Liu GS; Shen HH
Acta Biomater; 2021 May; 126():433-444. PubMed ID: 33774200
[TBL] [Abstract][Full Text] [Related]
29. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z
Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613
[No Abstract] [Full Text] [Related]
31. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
[TBL] [Abstract][Full Text] [Related]
32. Formation of particulate lipid lyotropic liquid crystalline nanocarriers using a microfluidic platform.
Yu H; Dyett BP; Zhai J; Strachan JB; Drummond CJ; Conn CE
J Colloid Interface Sci; 2023 Mar; 634():279-289. PubMed ID: 36542965
[TBL] [Abstract][Full Text] [Related]
33. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature.
Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C
Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent imaging using novel conjugated polymeric nanoparticles-affimer probes in complex
Jolugbo P; Willott T; Lin WH; Maisey T; O'Callaghan D; Green MA; Jayne DG; Khot MI
Nanoscale; 2023 Aug; 15(30):12476-12480. PubMed ID: 37466243
[TBL] [Abstract][Full Text] [Related]
35. Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
A Vahab S; Nair A; Raj D; G P A; P P S; S Kumar V
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3729-3746. PubMed ID: 38095651
[TBL] [Abstract][Full Text] [Related]
36. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds.
Dong YD; Larson I; Barnes TJ; Prestidge CA; Boyd BJ
ACS Appl Mater Interfaces; 2011 May; 3(5):1771-80. PubMed ID: 21506614
[TBL] [Abstract][Full Text] [Related]
37. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
[TBL] [Abstract][Full Text] [Related]
38. Amphiphilic brush polymers produced using the RAFT polymerisation method stabilise and reduce the cell cytotoxicity of lipid lyotropic liquid crystalline nanoparticles.
Zhai J; Suryadinata R; Luan B; Tran N; Hinton TM; Ratcliffe J; Hao X; Drummond CJ
Faraday Discuss; 2016 Oct; 191():545-563. PubMed ID: 27453499
[TBL] [Abstract][Full Text] [Related]
39. Coupling in vitro cell culture with synchrotron SAXS to understand the bio-interaction of lipid-based liquid crystalline nanoparticles with vascular endothelial cells.
Lam YY; Hawley A; Tan A; Boyd BJ
Drug Deliv Transl Res; 2020 Jun; 10(3):610-620. PubMed ID: 31997254
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid/polyethyleneimine nanoparticles loaded with copper ion and disulfiram for esophageal cancer.
Xu R; Zhang K; Liang J; Gao F; Li J; Guan F
Carbohydr Polym; 2021 Jun; 261():117846. PubMed ID: 33766342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
